Correlation Between Gain Therapeutics and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Champions Oncology, you can compare the effects of market volatilities on Gain Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Champions Oncology.
Diversification Opportunities for Gain Therapeutics and Champions Oncology
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Gain and Champions is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Champions Oncology go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Champions Oncology
Given the investment horizon of 90 days Gain Therapeutics is expected to generate 1.13 times more return on investment than Champions Oncology. However, Gain Therapeutics is 1.13 times more volatile than Champions Oncology. It trades about 0.0 of its potential returns per unit of risk. Champions Oncology is currently generating about -0.22 per unit of risk. If you would invest 214.00 in Gain Therapeutics on November 27, 2024 and sell it today you would lose (6.00) from holding Gain Therapeutics or give up 2.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. Champions Oncology
Performance |
| Timeline |
| Gain Therapeutics |
| Champions Oncology |
Gain Therapeutics and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Champions Oncology
The main advantage of trading using opposite Gain Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Gain Therapeutics vs. Biovie Inc | Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. NewAmsterdam Pharma | Gain Therapeutics vs. Cue Biopharma |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |